The recent emergence of nanomedicine has revolutionized
the therapeutic
landscape and necessitated the creation of more sophisticated drug
delivery systems. Polymeric nanoparticles sit at the forefront of
numerous promising drug delivery designs, due to their unmatched control
over physiochemical properties such as size, shape, architecture,
charge, and surface functionality. Furthermore, polymeric nanoparticles
have the ability to navigate various biological barriers to precisely
target specific sites within the body, encapsulate a diverse range
of therapeutic cargo and efficiently release this cargo in response
to internal and external stimuli. However, despite these remarkable
advantages, the presence of polymeric nanoparticles in wider clinical
application is minimal. This review will provide a comprehensive understanding
of polymeric nanoparticles as drug delivery vehicles. The biological
barriers affecting drug delivery will be outlined first, followed
by a comprehensive description of the various nanoparticle designs
and preparation methods, beginning with the polymers on which they
are based. The review will meticulously explore the current performance
of polymeric nanoparticles against a myriad of diseases including
cancer, viral and bacterial infections, before finally evaluating
the advantages and crucial challenges that will determine their wider
clinical potential in the decades to come.